Skip to main content
Equibles
NAMS $25.10 +0.72%
NAMS logo
NAMS · NewAmsterdam Pharma Co N.V.
Track NAMS — free

Use NAMS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$25.10 +0.18 (+0.72%)
Rebalance outlook locked
Market Cap
$2.98B
Shares
119.54M
All earnings calls

Earnings call · FY2026 Q2

NewAmsterdam Pharma Co N.V. (NAMS) Q2 2026 Earnings Call

Concluded Aug 5, 2026
Aug 5, 2026 0 turns
Period
FY2026 Q2
Runtime
—
Sources
3 artifacts
Slides 40 8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.

Research coverage

3 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Presentation 40 pages 8-K earnings release Filed Aug 5, 2026 10-Q report Filed Aug 5, 2026 Company webcastOpen the original investor-relations page
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)